查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587707

2030 年眼科器材市场预测：按产品、应用、最终用户和地区分類的全球分析

Ophthalmic Devices Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球眼科器材市场规模为 74 亿美元，预计到 2030 年将达到 103 亿美元，预测期内复合年增长率为 5.7%。

称为眼科设备的专用仪器和设备用于诊断、追踪和治疗各种眼科疾病。此类产品包括隐形眼镜、超音波乳化器、人工水晶体、裂隙灯和光同调断层扫瞄。这些仪器对于眼部保健、手术和视力改善至关重要。眼科医疗设备随着技术进步而不断发展，改善了世界各地眼科护理程序的患者治疗结果、准确性和效率。

根据世界卫生组织 (WHO) 统计，至少有 22 亿人患有近视或远视。其中至少有十亿人患有可预防或未经治疗的视力丧失。 90% 视力障碍和失明未解决的人生活在低收入和中等收入国家 (LMIC)。

视力障碍盛行率增加

青光眼、白内障和糖尿病视网膜病变等视力障碍发病率的增加是眼科医疗设备市场的关键驱动因素。随着世界人口老化，与老龄化相关的眼科疾病率增加，对诊断和治疗设备的需求增加。此外，萤幕时间增加和营养不良等生活方式因素也会导致屈光不正和其他眼科疾病的增加。这一趋势需要先进的眼科设备来进行早期检测、准确诊断和有效治疗，从而推动市场成长。

高成本

飞秒雷射和人工智慧诊断工具等最尖端科技价格昂贵，对于发展中地区和小型诊所的医疗保健提供者来说是遥不可及的。此外，使用这些设备进行治疗的高昂费用可能会让患者望而却步，尤其是在保险覆盖范围和报销选择有限的地区。这种成本障碍可能会减缓新技术的采用并限制市场扩张。

门诊手术中心增加

与传统医院相比，门诊手术中心为许多眼科手术提供了更具成本效益和效率的选择。这一趋势推动了对门诊病人使用的紧凑、便携式和易于使用的眼科设备的需求。 ASC 的兴起也促使製造商开发创新设备，以提高这些专业设施的手术效率和病患治疗效果。随着越来越多的患者选择方便且节省成本的 ASC，适应这种环境的眼科设备市场预计将显着成长。

与眼科手术相关的风险

儘管技术不断进步，白内障手术、 LASIK和视网膜手术等手术仍存在潜在的併发症，如感染疾病、视力丧失和需要额外手术。这些风险可能导致患者犹豫并加强监管机构的监督，从而减缓新手术技术和设备的采用。此外，与眼科医疗设备相关的引人注目的事件或召回可能会削弱消费者的信心并影响市场成长。

COVID-19 的影响：

由于选择性手术延迟和患者就诊次数减少，COVID-19 大流行最初扰乱了眼科器械市场。然而，大流行加速了远端医疗和远距离诊断工具在眼科领域的采用。疫情凸显了对创新非接触式测试设备的需求，刺激了人工智慧诊断解决方案的开拓，并可能重塑市场格局并推动数位眼技术的长期成长。

医院和诊所预计在预测期内将是最大的

预计医院和诊所部门将在预测期内占据市场占有率。这一优势归功于这些环境中提供的全面眼科护理服务，从常规检查到复杂的手术程序。医院和诊所通常有财力投资先进的眼科设备和技术，因此他们在采用新设备方面处于领先地位。此外，整合医院和专业眼科诊所眼科护理服务的趋势进一步巩固了该细分市场的市场主导地位。

屈光不良领域预计在预测期内复合年增长率最高

屈光不良领域预计在预测期内将出现良好的成长。这种快速增长是由于屈光的盛行率不断增加，特别是全球范围内的近视、远视和散光。萤幕时间增加、都市化和生活型态改变等因素导致这些疾病的发生率上升。该领域的成长将进一步受到诊断和治疗设备技术进步的推动，例如先进的波前像差仪和用于屈光矫正手术的飞秒雷射。

占比最大的地区：

预计北美地区在预测期内将占据最大的市场占有率。这一优势得益于该地区先进的医疗基础设施、高昂的医疗成本以及较早采用创新医疗技术。北美主要市场参与者和研究机构的存在促进了眼科医疗设备的持续创新和产品开发。此外，该地区人口老化和眼科疾病率高，加上优惠的报销政策和眼部健康意识的提高，导致该地区对眼科医疗设备的强劲需求。

复合年增长率最高的地区：

预计亚太地区在预测期内的复合年增长率最高。这种快速增长归因于该地区人口众多且不断增长、眼科疾病率不断上升以及医疗基础设施的改善。在中国和印度等国家，可支配收入的增加和眼睛健康意识的提高正在推动对先进眼科护理的需求。该地区的眼保健医疗旅游也在迅速增长，特别是在以具有竞争力的价格提供高品质护理的国家。此外，政府改善医疗保健服务和扩大私人眼科护理设施的倡议正在为市场成长创造有利条件。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球眼科器材市场：依产品

  • 诊断和监测设备
    • 光学同调断层扫描装置
    • 眼底摄影机
    • 视野/视野分析仪
    • 自动验光仪和角膜曲率计
    • 眼压计
    • 裂隙灯
    • 综合屈光检查
    • 波前像差仪
    • 光学生物辨识系统
    • 眼底镜
    • 焦度计
    • 角膜地图仪系统
    • 镜面显微镜
    • 检影镜
  • 手术设备
    • 白内障手术装置
    • 青光眼手术设备
    • 屈光矫正手术装置
    • 玻璃体视网膜手术装置
  • 视力保健产品
    • 隐形眼镜
    • 眼镜镜片
  • 眼科超音波影像系统
    • 眼科A扫描超音波
    • 眼科B超音波
    • 超音波超音波生物显微镜
    • 眼科角膜测厚器
  • 其他产品

第六章全球眼科器材市场：依应用分类

  • 白内障
  • 青光眼
  • 屈光不正
  • 糖尿病视网膜病变
  • 老龄化黄斑部病变（AMD）
  • 干眼症
  • 其他用途

第七章全球眼科器材市场：依最终使用者分类

  • 医院和诊所
  • 日间手术中心 (ASC)
  • 眼科治疗
  • 研究所

第八章全球眼科器材市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、合作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第 10 章 公司概况

  • Alcon Inc.
  • Johnson & Johnson Vision Care
  • Bausch Health Companies Inc
  • Carl Zeiss Meditec AG
  • EssilorLuxottica SA
  • Hoya Corporation
  • Nidek Co. Ltd
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG
  • Haag-Streit Group
  • Volk Optical Inc
  • Optovue Inc
  • Glaukos Corporation
  • STAAR Surgical Co
  • Canon Inc
  • Novartis AG
  • Cooper Companies, Inc
  • Iridex Corporation
Product Code: SMRC27700

According to Stratistics MRC, the Global Ophthalmic Devices Market is accounted for $7.4 billion in 2024 and is expected to reach $10.3 billion by 2030, growing at a CAGR of 5.7% during the forecast period. Specialized instruments and tools known as ophthalmic devices are used to diagnose, track, and treat a variety of eye disorders. Products in this category include contact lenses, phacoemulsification equipment, intraocular lenses, slit lamps, and optical coherence tomography machines. These tools are essential for managing eye health, performing surgeries, and improving vision. Ophthalmic devices continue to evolve as a result of technological advancements, improving patient outcomes, accuracy, and efficiency in eye care procedures all over the world.

According to the World Health Organization (WHO), at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these cases, vision impairment could have been prevented or is yet to be addressed. And of those with unaddressed vision impairment or blindness, 90% live in low- and middle-income countries (LMICs).

Market Dynamics:

Driver:

Increasing prevalence of optical disorders

The rising incidence of optical disorders such as glaucoma, cataracts, and diabetic retinopathy is a significant driver for the ophthalmic devices market. As the global population ages, the prevalence of age-related eye conditions increases, creating a growing demand for diagnostic and treatment devices. Additionally, lifestyle factors like increased screen time and poor nutrition contribute to the rise in refractive errors and other eye problems. This trend necessitates advanced ophthalmic devices for early detection, accurate diagnosis, and effective treatment, thereby fueling market growth.

Restraint:

High costs

Cutting-edge technologies like femtosecond lasers and AI-powered diagnostic tools come with substantial price tags, making them less accessible to healthcare providers in developing regions or smaller clinics. Moreover, the high cost of treatments using these devices can be prohibitive for patients, especially in areas with limited insurance coverage or reimbursement options. This cost barrier can slow down the adoption of new technologies and limit market expansion.

Opportunity:

Increase in ambulatory surgery centers

ASCs offer a more cost-effective and efficient alternative to traditional hospital settings for many ophthalmic procedures. This trend is driving demand for compact, portable, and user-friendly ophthalmic devices tailored to outpatient settings. The rise of ASCs also encourages manufacturers to develop innovative devices that enhance procedural efficiency and patient outcomes in these specialized facilities. As more patients opt for the convenience and reduced costs of ASCs, the market for ophthalmic devices adapted to these settings is expected to expand considerably.

Threat:

Risk associated with ophthalmic surgeries

Despite technological advancements, procedures like cataract surgery, LASIK, and retinal surgeries carry potential complications such as infection, vision loss, or the need for additional surgeries. These risks can lead to patient hesitation and increased scrutiny from regulatory bodies, potentially slowing down the adoption of new surgical techniques and devices. Additionally, any high-profile incidents or recalls related to ophthalmic devices can damage consumer confidence and impact market growth.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the ophthalmic devices market due to postponed elective surgeries and reduced patient visits. However, it also accelerated the adoption of telemedicine and remote diagnostic tools in ophthalmology. The pandemic highlighted the need for innovative, contactless examination devices and spurred the development of AI-powered diagnostic solutions, reshaping the market landscape and potentially driving long-term growth in digital ophthalmic technologies.

The hospitals and clinics segment is expected to be the largest during the forecast period

Over the forecasted timeframe, the hospitals and clinics segment is anticipated to dominate the market share. This dominance can be attributed to the comprehensive range of eye care services offered in these settings, from routine check-ups to complex surgical procedures. Hospitals and clinics typically have the financial resources to invest in advanced ophthalmic equipment and technologies, making them primary adopters of new devices. Additionally, the trend towards integrated eye care services in hospitals and specialized eye clinics further solidifies this segment's leading position in the market.

The refractive disorders segment is expected to have the highest CAGR during the forecast period

The refractive disorders segment is expected to register lucrative growth during the estimation period. This rapid growth can be attributed to the increasing prevalence of refractive errors worldwide, particularly myopia, hyperopia, and astigmatism. Factors such as increased screen time, urbanization, and changing lifestyles contribute to the rising incidence of these disorders. The segment's growth is further fueled by technological advancements in diagnostic and treatment devices, including advanced wavefront aberrometers and femtosecond lasers for refractive surgeries.

Region with largest share:

Over the forecast period, the North America region is anticipated to hold the largest market share. This dominance can be attributed to the region's advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. The presence of major market players and research institutions in North America drives continuous innovation and product development in ophthalmic devices. Additionally, the region's aging population and high prevalence of eye disorders, coupled with favorable reimbursement policies and increased awareness of eye health, contribute to the strong demand for ophthalmic devices in the region.

Region with highest CAGR:

Over the forecasted timeframe, the Asia Pacific region is anticipated to exhibit the highest CAGR. This rapid growth can be attributed to the region's large and growing population, increasing prevalence of eye disorders, and improving healthcare infrastructure. Rising disposable incomes and growing awareness of eye health in countries like China and India are driving demand for advanced ophthalmic treatments. The region is also witnessing a surge in medical tourism for eye care, particularly in countries offering high-quality treatments at competitive prices. Moreover, government initiatives to improve healthcare access and the expansion of private eye care facilities are creating favorable conditions for market growth.

Key players in the market

Some of the key players in Ophthalmic Devices Market include Alcon Inc., Johnson & Johnson Vision Care, Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, Hoya Corporation, Nidek Co. Ltd., Topcon Corporation, Ziemer Ophthalmic Systems AG, Haag-Streit Group, Volk Optical Inc., Optovue Inc., Glaukos Corporation, STAAR Surgical Co., Canon Inc., Novartis AG, Cooper Companies, Inc., and Iridex Corporation.

Key Developments:

In September 2024, Johnson & Johnson, a global leader in eye health, announced the expansion of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOL), TECNIS Odyssey, in the U.S. The new full visual range IOL offers patients unmatched continuous full range of vision, allowing them to see clearly from far to near and in between, minimizing their need for glasses. The TECNIS Odyssey IOL is built on the TECNIS platform, providing twice the contrast in low lighting compared to PanOptix.

In July 2024, Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the closing of its deal to acquire BELKIN Vision with a total upfront consideration of $81M, including a cash payment of approximately $65M.

In April 2024, Carl Zeiss Meditec AG announced that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. The acquisition enhances and complements ZEISS Medical Technology's broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, spanning retina and cornea disorders, cataract, glaucoma, and refractive errors.

Products Covered:

  • Diagnostic and Monitoring Devices
  • Surgical Devices
  • Vision Care Products
  • Ophthalmic Ultrasound Imaging Systems
  • Other Products

Applications Covered:

  • Cataract
  • Glaucoma
  • Refractive Disorders
  • Diabetic Retinopathy
  • Age-Related Macular Degeneration (AMD)
  • Dry Eye
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Ophthalmic Practices
  • Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ophthalmic Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Diagnostic and Monitoring Devices
    • 5.2.1 Optical Coherence Tomography Scanners
    • 5.2.2 Fundus Cameras
    • 5.2.3 Perimeters/Visual Field Analysers
    • 5.2.4 Autorefractors and Keratometers
    • 5.2.5 Tonometers
    • 5.2.6 Slit Lamps
    • 5.2.7 Phoropters
    • 5.2.8 Wavefront Aberrometers
    • 5.2.9 Optical Biometry Systems
    • 5.2.10 Ophthalmoscopes
    • 5.2.11 Lensmeters
    • 5.2.12 Corneal Topography Systems
    • 5.2.13 Specular Microscopes
    • 5.2.14 Retinoscopes
  • 5.3 Surgical Devices
    • 5.3.1 Cataract Surgery Devices
    • 5.3.2 Glaucoma Surgery Devices
    • 5.3.3 Refractive Surgery Devices
    • 5.3.4 Vitreoretinal Surgery Devices
  • 5.4 Vision Care Products
    • 5.4.1 Contact Lenses
    • 5.4.2 Spectacle Lenses
  • 5.5 Ophthalmic Ultrasound Imaging Systems
    • 5.5.1 Ophthalmic A-Scan Ultrasound
    • 5.5.2 Ophthalmic B-Scan Ultrasound
    • 5.5.3 Ophthalmic Ultrasound Biomicroscopes
    • 5.5.4 Ophthalmic Pachymeters
  • 5.6 Other Products

6 Global Ophthalmic Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Cataract
  • 6.3 Glaucoma
  • 6.4 Refractive Disorders
  • 6.5 Diabetic Retinopathy
  • 6.6 Age-Related Macular Degeneration (AMD)
  • 6.7 Dry Eye
  • 6.8 Other Applications

7 Global Ophthalmic Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals and Clinics
  • 7.3 Ambulatory Surgery Centers (ASCs)
  • 7.4 Ophthalmic Practices
  • 7.5 Research Institutes

8 Global Ophthalmic Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Alcon Inc.
  • 10.2 Johnson & Johnson Vision Care
  • 10.3 Bausch Health Companies Inc
  • 10.4 Carl Zeiss Meditec AG
  • 10.5 EssilorLuxottica SA
  • 10.6 Hoya Corporation
  • 10.7 Nidek Co. Ltd
  • 10.8 Topcon Corporation
  • 10.9 Ziemer Ophthalmic Systems AG
  • 10.10 Haag-Streit Group
  • 10.11 Volk Optical Inc
  • 10.12 Optovue Inc
  • 10.13 Glaukos Corporation
  • 10.14 STAAR Surgical Co
  • 10.15 Canon Inc
  • 10.16 Novartis AG
  • 10.17 Cooper Companies, Inc
  • 10.18 Iridex Corporation

List of Tables

  • Table 1 Global Ophthalmic Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Ophthalmic Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Ophthalmic Devices Market Outlook, By Diagnostic and Monitoring Devices (2022-2030) ($MN)
  • Table 4 Global Ophthalmic Devices Market Outlook, By Optical Coherence Tomography Scanners (2022-2030) ($MN)
  • Table 5 Global Ophthalmic Devices Market Outlook, By Fundus Cameras (2022-2030) ($MN)
  • Table 6 Global Ophthalmic Devices Market Outlook, By Perimeters/Visual Field Analysers (2022-2030) ($MN)
  • Table 7 Global Ophthalmic Devices Market Outlook, By Autorefractors and Keratometers (2022-2030) ($MN)
  • Table 8 Global Ophthalmic Devices Market Outlook, By Tonometers (2022-2030) ($MN)
  • Table 9 Global Ophthalmic Devices Market Outlook, By Slit Lamps (2022-2030) ($MN)
  • Table 10 Global Ophthalmic Devices Market Outlook, By Phoropters (2022-2030) ($MN)
  • Table 11 Global Ophthalmic Devices Market Outlook, By Wavefront Aberrometers (2022-2030) ($MN)
  • Table 12 Global Ophthalmic Devices Market Outlook, By Optical Biometry Systems (2022-2030) ($MN)
  • Table 13 Global Ophthalmic Devices Market Outlook, By Ophthalmoscopes (2022-2030) ($MN)
  • Table 14 Global Ophthalmic Devices Market Outlook, By Lensmeters (2022-2030) ($MN)
  • Table 15 Global Ophthalmic Devices Market Outlook, By Corneal Topography Systems (2022-2030) ($MN)
  • Table 16 Global Ophthalmic Devices Market Outlook, By Specular Microscopes (2022-2030) ($MN)
  • Table 17 Global Ophthalmic Devices Market Outlook, By Retinoscopes (2022-2030) ($MN)
  • Table 18 Global Ophthalmic Devices Market Outlook, By Surgical Devices (2022-2030) ($MN)
  • Table 19 Global Ophthalmic Devices Market Outlook, By Cataract Surgery Devices (2022-2030) ($MN)
  • Table 20 Global Ophthalmic Devices Market Outlook, By Glaucoma Surgery Devices (2022-2030) ($MN)
  • Table 21 Global Ophthalmic Devices Market Outlook, By Refractive Surgery Devices (2022-2030) ($MN)
  • Table 22 Global Ophthalmic Devices Market Outlook, By Vitreoretinal Surgery Devices (2022-2030) ($MN)
  • Table 23 Global Ophthalmic Devices Market Outlook, By Vision Care Products (2022-2030) ($MN)
  • Table 24 Global Ophthalmic Devices Market Outlook, By Contact Lenses (2022-2030) ($MN)
  • Table 25 Global Ophthalmic Devices Market Outlook, By Spectacle Lenses (2022-2030) ($MN)
  • Table 26 Global Ophthalmic Devices Market Outlook, By Ophthalmic Ultrasound Imaging Systems (2022-2030) ($MN)
  • Table 27 Global Ophthalmic Devices Market Outlook, By Ophthalmic A-Scan Ultrasound (2022-2030) ($MN)
  • Table 28 Global Ophthalmic Devices Market Outlook, By Ophthalmic B-Scan Ultrasound (2022-2030) ($MN)
  • Table 29 Global Ophthalmic Devices Market Outlook, By Ophthalmic Ultrasound Biomicroscopes (2022-2030) ($MN)
  • Table 30 Global Ophthalmic Devices Market Outlook, By Ophthalmic Pachymeters (2022-2030) ($MN)
  • Table 31 Global Ophthalmic Devices Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 32 Global Ophthalmic Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 33 Global Ophthalmic Devices Market Outlook, By Cataract (2022-2030) ($MN)
  • Table 34 Global Ophthalmic Devices Market Outlook, By Glaucoma (2022-2030) ($MN)
  • Table 35 Global Ophthalmic Devices Market Outlook, By Refractive Disorders (2022-2030) ($MN)
  • Table 36 Global Ophthalmic Devices Market Outlook, By Diabetic Retinopathy (2022-2030) ($MN)
  • Table 37 Global Ophthalmic Devices Market Outlook, By Age-Related Macular Degeneration (AMD) (2022-2030) ($MN)
  • Table 38 Global Ophthalmic Devices Market Outlook, By Dry Eye (2022-2030) ($MN)
  • Table 39 Global Ophthalmic Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 40 Global Ophthalmic Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 41 Global Ophthalmic Devices Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 42 Global Ophthalmic Devices Market Outlook, By Ambulatory Surgery Centers (ASCs) (2022-2030) ($MN)
  • Table 43 Global Ophthalmic Devices Market Outlook, By Ophthalmic Practices (2022-2030) ($MN)
  • Table 44 Global Ophthalmic Devices Market Outlook, By Research Institutes (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.